|
1
|
Engstrom PF, Arnoletti JP, Benson AB III,
Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS,
Enzinger PC, et al: NCCN clinical practice guidelines in oncology:
Colon cancer. J Natl Compr Canc Netw. 7:778–831. 2009.PubMed/NCBI
|
|
2
|
Liu K, Zhang W, Chen X, Chen X, Yang K,
Zhang B, Chen Z, Zhou Z and Hu J: Comparison on clinicopathological
features and prognosis between esophagogastric junctional
adenocarcinoma (Siewert II/III Types) and distal gastric
adenocarcinoma: Retrospective cohort study, a single institution,
high volume experience in china. Medicine (Baltimore).
94:e13862015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vial M, Grande L and Pera M: Epidemiology
of adenocarcinoma of the esophagus, gastric cardia, and upper
gastric third. Recent Results Cancer Res. 182:1–17. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Buas MF and Vaughan TL: Epidemiology and
risk factors for gastroesophageal junction tumors: Understanding
the rising incidence of this disease. Semin Radiat Oncol. 23:3–9.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Siewert JR, Feith M and Stein HJ: Biologic
and clinical variations of adenocarcinoma at the esophago-gastric
junction: Relevance of a topographic-anatomic subclassification. J
Surg Oncol. 90:139–146. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lang F, Böhmer C, Palmada M, Seebohm G,
Strutz-Seebohm N and Vallon V: (Patho) physiological significance
of the serum-and glucocorticoid-inducible kinase isoforms. Physiol
Rev. 86:1151–1178. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lang F and Cohen P: Regulation and
physiological roles of serum-and glucocorticoid-induced protein
kinase isoforms. Sci STKE. 2001:re172001.PubMed/NCBI
|
|
8
|
Brunet A, Park J, Tran H, Hu LS, Hemmings
BA and Greenberg ME: Protein kinase SGK mediates survival signals
by phosphorylating the forkhead transcription factor FKHRL1
(FOXO3a). Mol Cell Biol. 21:952–965. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lang F, Henke G, Embark HM, Waldegger S,
Palmada M, Böhmer C and Vallon V: Regulation of channels by the
serum and glucocorticoid-inducible kinase-implications for
transport, excitability and cell proliferation. Cell Physiol
Biochem. 13:41–50. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nasir O, Wang K, Föller M, Gu S, Bhandaru
M, Ackermann TF, Boini KM, Mack A, Klingel K, Amato R, et al:
Relative resistance of SGK1 knockout mice against chemical
carcinogenesis. IUBMB Life. 61:768–776. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sommer EM, Dry H, Cross D, Guichard S,
Davies BR and Alessi DR: Elevated SGK1 predicts resistance of
breast cancer cells to Akt inhibitors. Biochem J. 452:499–508.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Abbruzzese C, Mattarocci S, Pizzuti L,
Mileo AM, Visca P, Antoniani B, Alessandrini G, Facciolo F, Amato
R, D'Antona L, et al: Determination of SGK1 mRNA in non-small cell
lung cancer samples underlines high expression in squamous cell
carcinomas. J Exp Clin Cancer Res. 31:42012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Talarico C, D'Antona L, Scumaci D, Barone
A, Gigliotti F, Fiumara CV, Dattilo V, Gallo E, Visca P, Ortuso F,
et al: Preclinical model in HCC: The SGK1 kinase inhibitor SI113
blocks tumor progression in vitro and in vivo and synergizes with
radiotherapy. Oncotarget. 6:37511–37525. 2015.PubMed/NCBI
|
|
14
|
Rauhala HE, Porkka KP, Tolonen TT,
Martikainen PM, Tammela TL and Visakorpi T: Dual-specificity
phosphatase 1 and serum/glucocorticoid-regulated kinase are
downregulated in prostate cancer. Int J Cancer. 117:738–745. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chu S, Rushdi S, Zumpe ET, Mamers P, Healy
DL, Jobling T, Burger HG and Fuller PJ: FSH-regulated gene
expression profiles in ovarian tumours and normal ovaries. Mol Hum
Reprod. 8:426–433. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ronchi CL, Sbiera S, Leich E, Tissier F,
Steinhauer S, Deutschbein T, Fassnacht M and Allolio B: Low SGK1
expression in human adrenocortical tumors is associated with
ACTH-independent glucocorticoid secretion and poor prognosis. J
Clin Endocrinol Metab. 97:E2251–E2260. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pirker R, Pereira JR, von Pawel J,
Krzakowski M, Ramlau R, Park K, de Marinis F, Eberhardt WE,
Paz-Ares L, Störkel S, et al: EGFR expression as a predictor of
survival for first-line chemotherapy plus cetuximab in patients
with advanced non-small-cell lung cancer: Analysis of data from the
phase 3 FLEX study. Lancet Oncol. 13:33–42. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Webster MK, Goya L, Ge Y, Maiyar AC and
Firestone GL: Characterization of sgk, a novel member of the
serine/threonine protein kinase gene family which is
transcriptionally induced by glucocorticoids and serum. Mol Cell
Biol. 13:2031–2040. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Park J, Leong ML, Buse P, Maiyar AC,
Firestone GL and Hemmings BA: Serum and glucocorticoid-inducible
kinase (SGK) is a target of the PI3-kinase-stimulated signaling
pathway. EMBO J. 18:3024–3033. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kobayashi T and Cohen P: Activation of
serum-and glucocorticoid-regulated protein kinase by agonists that
activate phosphatidylinositide 3-kinase is mediated by
3-phosphoinositide-dependent protein kinase-1 (PDK1) and PDK2.
Biochem J. 339:319–328. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mundi PS, Sachdev J, McCourt C and
Kalinsky K: AKT in cancer: New molecular insights and advances in
drug development. Br J Clin Pharmacol. 82:943–956. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu C, Yosef N, Thalhamer T, Zhu C, Xiao S,
Kishi Y, Regev A and Kuchroo VK: Induction of pathogenic TH17 cells
by inducible salt-sensing kinase SGK1. Nature. 496:513–517. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou H, Gao S, Duan X, Liang S, Scott DA,
Lamont RJ and Wang H: Inhibition of serum-and
glucocorticoid-inducible kinase 1 enhances TLR-mediated
inflammation and promotes endotoxin-driven organ failure. FASEB J.
29:3737–3749. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gu Z, Lamont GJ, Lamont RJ, Uriarte SM,
Wang H and Scott DA: Resolvin D1, resolvin D2 and maresin 1
activate the GSK3β anti-inflammatory axis in TLR4-engaged human
monocytes. Innate Immun. 22:186–195. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bhatelia K, Singh K and Singh R: TLRs:
Linking inflammation and breast cancer. Cell Signal. 26:2350–2357.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gao S, Brown J, Wang H and Feng X: The
role of glycogen synthase kinase 3-β in immunity and cell cycle:
Implications in esophageal cancer. Arch Immunol Ther Exp (Warsz).
62:131–144. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dehner M, Hadjihannas M, Weiske J, Huber O
and Behrens J: Wnt signaling inhibits Forkhead box O3a-induced
transcription and apoptosis through up-regulation of serum-and
glucocorticoid-inducible kinase 1. J Biol Chem. 283:19201–19210.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang H and Tindall DJ: Dynamic FoxO
transcription factors. J Cell Sci. 120:2479–2487. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
You H, Jang YJ, You-Ten AI, Okada H, Liepa
J, Wakeham A, Zaugg K and Mak TW: p53-dependent inhibition of
FKHRL1 in response to DNA damage through protein kinase SGK1. Proc
Natl Acad Sci USA. 101:14057–14062. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Brunet A, Park J, Tran H, Hu LS, Hemmings
BA and Greenberg ME: Protein kinase SGK mediates survival signals
by phosphorylating the forkhead transcription factor FKHRL1
(FOXO3a). Mol Cell Biol. 21:952–965. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Borst O, Schaub M, Walker B, Schmid E,
Münzer P, Voelkl J, Alesutan I, Rodríguez JM, Vogel S, Schoenberger
T, et al: Pivotal role of serum-and glucocorticoid-inducible kinase
1 in vascular inflammation and atherogenesis. Arterioscler Thromb
Vasc Biol. 35:547–557. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mikosz CA, Brickley DR, Sharkey MS, Moran
TW and Conzen SD: Glucocorticoid receptor-mediated protection from
apoptosis is associated with induction of the serine/threonine
survival kinase gene, sgk-1. J Biol Chem. 276:16649–16654. 2001.
View Article : Google Scholar : PubMed/NCBI
|
